242 related articles for article (PubMed ID: 24731281)
1. Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents.
Yuan JW; Wang SF; Luo ZL; Qiu HY; Wang PF; Zhang X; Yang YA; Yin Y; Zhang F; Zhu HL
Bioorg Med Chem Lett; 2014 May; 24(10):2324-8. PubMed ID: 24731281
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents.
Dawood KM; Eldebss TM; El-Zahabi HS; Yousef MH; Metz P
Eur J Med Chem; 2013; 70():740-9. PubMed ID: 24231309
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF(V⁶⁰⁰E) inhibitors.
Zhao MY; Yin Y; Yu XW; Sangani CB; Wang SF; Lu AM; Yang LF; Lv PC; Jiang MG; Zhu HL
Bioorg Med Chem; 2015 Jan; 23(1):46-54. PubMed ID: 25496804
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors.
Wang SF; Zhu YL; Zhu PT; Makawana JA; Zhang YL; Zhao MY; Lv PC; Zhu HL
Bioorg Med Chem; 2014 Nov; 22(21):6201-8. PubMed ID: 25267006
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-proliferative activity of some new quinoline based 4,5-dihydropyrazoles and their thiazole hybrids as EGFR inhibitors.
George RF; Samir EM; Abdelhamed MN; Abdel-Aziz HA; Abbas SE
Bioorg Chem; 2019 Mar; 83():186-197. PubMed ID: 30380447
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.
Wang HH; Qiu KM; Cui HE; Yang YS; Yin-Luo ; Xing M; Qiu XY; Bai LF; Zhu HL
Bioorg Med Chem; 2013 Jan; 21(2):448-55. PubMed ID: 23245802
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro anticancer evaluation and in silico studies of novel imidazo[2,1-b]thiazole derivatives bearing pyrazole moieties.
Ali AR; El-Bendary ER; Ghaly MA; Shehata IA
Eur J Med Chem; 2014 Mar; 75():492-500. PubMed ID: 24576591
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
[TBL] [Abstract][Full Text] [Related]
11. SAR-based optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as highly potent EP1 receptor antagonists.
Atobe M; Naganuma K; Kawanishi M; Morimoto A; Kasahara K; Ohashi S; Suzuki H; Hayashi T; Miyoshi S
Bioorg Med Chem Lett; 2013 Dec; 23(24):6569-76. PubMed ID: 24252546
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and molecular modeling of dihydro-pyrazolyl-thiazolinone derivatives as potential COX-2 inhibitors.
Qiu KM; Yan R; Xing M; Wang HH; Cui HE; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(22):6648-54. PubMed ID: 23062711
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems.
Rostom SA
Bioorg Med Chem; 2006 Oct; 14(19):6475-85. PubMed ID: 16806944
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.
Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R
Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents.
Lv PC; Li HQ; Sun J; Zhou Y; Zhu HL
Bioorg Med Chem; 2010 Jul; 18(13):4606-14. PubMed ID: 20627597
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
[TBL] [Abstract][Full Text] [Related]
17. Substituted thiazoles VII. Synthesis and antitumor activity of certain 2-(substituted amino)-4-phenyl-1,3-thiazole analogs.
Hassan GS; El-Messery SM; Al-Omary FA; El-Subbagh HI
Bioorg Med Chem Lett; 2012 Oct; 22(20):6318-23. PubMed ID: 22995621
[TBL] [Abstract][Full Text] [Related]
18. A novel series of thiazolyl-pyrazoline derivatives: synthesis and evaluation of antifungal activity, cytotoxicity and genotoxicity.
Altıntop MD; Özdemir A; Turan-Zitouni G; Ilgın S; Atlı Ö; Demirel R; Kaplancıklı ZA
Eur J Med Chem; 2015 Mar; 92():342-52. PubMed ID: 25576739
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential.
Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM
Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Characterization, and Biological Activity of a Novel Series of Benzo[4,5]imidazo[2,1-
Deng X; Tan X; An T; Ma Q; Jin Z; Wang C; Meng Q; Hu C
Molecules; 2019 Feb; 24(4):. PubMed ID: 30769844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
